PD-1 blockade at the time of tumor escape potentiates the immune-mediated antitumor effects of a melanoma-targeting monoclonal antibody

DOI: 10.1080/2162402X.2017.1353857

Keywords: anti-tumor immunity, combined therapies, immunomodulation, long-lasting effects, tumor escape, tumor immune microenvironment, tumor-targeting monoclonal antibodies

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text